GLP-1 tablets: what options are available in Spain today

Why do people search for “Ozempic tablets”?

Ozempic is semaglutide in an injectable pen, and that is the only form it comes in. There is no tablet form sold under that brand name [1]. When someone searches for “Ozempic tablets”, they usually mean Rybelsus, which contains the same active ingredient, semaglutide, as a once-daily tablet authorised for type 2 diabetes [1][2].

They contain the same molecule, but they are different medicines. The dose, how you take them and, in part, what each is approved for are different. If you have a prescription for either one, do not switch between them on your own.

The same confusion comes up with “Wegovy tablets”. Injectable Wegovy and oral Wegovy are different forms of the same medicine, each with its own instructions [3]. Clarifying this before looking for a price or a pharmacy helps avoid comparing things that are not the same.

Ozempic and Rybelsus contain the same molecule, but their instructions, doses and indications are different.

Rybelsus: the GLP-1 tablet that is available in Spain

Rybelsus is semaglutide in tablet form, authorised in Spain for adults with type 2 diabetes, alongside diet and exercise [2]. Take one tablet a day after fasting for at least 8 hours. Swallow it whole with a sip of water, up to 120 ml [2].

Then wait at least 30 minutes before eating breakfast, drinking anything else or taking other medicines by mouth [2]. That waiting time matters. If you shorten it or take the tablet with food, your body absorbs less semaglutide, and the amount absorbed can be unpredictable [2].

Rybelsus is not authorised for weight loss in people without type 2 diabetes. That is the indication for Wegovy, which has its own prescription and medical assessment [3]. If you miss a dose, skip it and take your next dose the following day; do not take a double dose [2].

• Take it as soon as you get up, before doing anything else.
• Swallow the tablet whole, without splitting or chewing it, with a sip of water.
• Wait the full 30 minutes before having coffee, breakfast or the rest of your medicines.

The Rybelsus page has the full instructions, dose escalation and the most common digestive side effects.

Oral Wegovy and orforglipron: when will they be available in Spain?

Two more GLP-1 tablets have already been authorised, but neither is on sale in Spain yet, and there is no confirmed arrival date. The weight-loss figures below are trial averages; each person responds differently.

Oral Wegovy is semaglutide in tablet form, at up to 25 mg a day, with the same indication as injectable Wegovy: weight management [3]. The European Union authorised it in 2026, but it has not yet reached Spanish pharmacies [3][5]. In its main trial, people who took it lost an average of 13.6% of their body weight over 64 weeks [6]. Among those who followed the instructions without missing doses, the average reached 16.6% [6].

Orforglipron, marketed as Foundayo, is a different active ingredient from semaglutide, designed from the outset to be taken as a tablet. It is approved in the United States [7] and in the United Kingdom, the first European country to do so [4]. It has not yet been authorised in the European Union, including Spain [4].

In its main trial, at the highest dose, average weight loss was 11.2% over 72 weeks, and 12.4% among those who stayed on treatment [8]. Unlike Rybelsus, it can be taken with or without food, without fasting beforehand [7].

For more detail, see the pages on Wegovy, including its oral form, and orforglipron.

Is the tablet better than the injection?

Not automatically. Oral semaglutide is absorbed much less effectively than injected semaglutide. Only a small and variable amount of each Rybelsus tablet reaches the bloodstream. That is why much higher doses in milligrams are needed than with the pen to achieve a similar effect [2].

This absorption pattern requires stricter instructions: an 8-hour fast, only a small amount of water, and a 30-minute wait before eating, drinking or taking another tablet [2]. Oral Wegovy has the same requirement [3]. Orforglipron does not [7].

The Rybelsus product information is clear. Absorption of oral semaglutide is highly variable, and between 2% and 4% of people who take it absorb none at all [2]. This means its effect depends much more on following the instructions to the letter than a weekly injection does.

For many people, avoiding injections is a real convenience; for others, so is having a fasting routine every morning. Neither the tablet nor the injection is the right option for everyone. The right one is the option your doctor considers suitable for your diagnosis, routine and tolerance.

If you find tablets difficult to swallow, already take several medicines in the morning, or cannot fit a half-hour wait into your routine, mention this before deciding. It may affect which option fits your day.

What we hear in consultations

Two questions come up repeatedly. The first is: “If it is the same molecule, why does the tablet contain so many more milligrams?” It is because of the absorption described above. The number of milligrams on the pack cannot be compared between the pen and the tablet [2].

The second is: “Can I switch from Ozempic to Rybelsus, or the other way round, on my own?” No. Changing the route of administration requires a prescription, because the dose of one cannot be converted to the other using a simple ratio [1][2].

People also ask whether they can split or crush the tablet to make it easier to swallow. No: the Rybelsus product information says to swallow it whole, because it is not known whether splitting it changes how much semaglutide is absorbed [2].

If you take insulin or medicines that can lower your blood sugar too much, mention this at your nutrition appointment too. Your meal plan may need to be adapted to help prevent a drop in blood glucose [2].